🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438
Primary objective is to evaluate the immune response to vaccination with te...
Status
Completed
Location
Research Site
Start Date
2015-02-28
Trial ID
NCT02097849
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
The purpose of this study is to collect serum samples for use as quality co...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-01
Trial ID
NCT02072525
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested
This safety surveillance study of GlaxoSmithKline's quadrivalent meningococ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02287688
Treatments Being Tested
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-22
Trial ID
NCT02199691
Treatments Being Tested
Invasive meningococcal disease is a worldwide problem with serious repercus...
Status
Completed
Location
Leiden University Medical Center
Start Date
2013-01
Trial ID
NCT01782066
Treatments Being Tested